SCHEMBL2301074

SCHEMBL2301074

O=C(O)C1=CC=CNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10438113 0.98 BLM (0.41)
Hydrochloric Acid SCHEMBL17597680 0.98 BLM (0.41)
Trifluoroacetic Acid SCHEMBL17595021 0.89 TSHR (0.33)
SCHEMBL4242319 0.83
SCHEMBL1017726 0.80
Hydrochloric Acid SCHEMBL30468940 0.78 THRB (0.36)
SCHEMBL22411680 0.78
SCHEMBL5660573 0.75 HDAC2 (0.31)
SCHEMBL3391017 0.75 KDM5B (0.33)
SCHEMBL4771907 0.73 ALDH1A1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 220 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250388543-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-12-25 US claimed
US-20250367229-A1 Treatment of Immune-Related Disorders, Kidney Disorders, Liver Disorders, Hemolytic Disorders, and Oxidative Stress-Associated Disorders Using NRH, NARH and Reduced Derivatives Thereof MITOPOWER LLC (US) 2025-12-04 US claimed
WO-2025003367-A1 VITAMIN COMPOSITION FOR USE IN COSMETIC FORMULATIONS CLARIANT INTERNATIONAL LTD (CH) 2025-01-02 WO claimed
US-20240382512-A1 Treatment of Immune-Related Disorders, Kidney Disorders, Liver Disorders, Hemolytic Disorders, and Oxidative Stress-Associated Disorders Using NRH, NARH and Reduced Derivatives Thereof MITOPOWER LLC 2024-11-21 US claimed
EP-4313067-A1 TREATMENT OF IMMUNE-RELATED DISORDERS, KIDNEY DISORDERS, LIVER DISORDERS, HEMOLYTIC DISORDERS, AND OXIDATIVE STRESS-ASSOCIATED DISORDERS USING NRH, NARH AND REDUCED DERIVATIVES THEREOF Mitopower LLC (US) 2024-02-07 EP claimed
US-20230014055-A1 Treatment of Immune-Related Disorders, Kidney Disorders, Liver Disorders, Hemolytic Disorders, and Oxidative Stress-Associated Disorders Using NRH, NARH and Reduced Derivatives Thereof MITOPOWER LLC 2023-01-19 US claimed
WO-2022266322-A1 TREATMENT OF IMMUNE-RELATED DISORDERS, KIDNEY DISORDERS, LIVER DISORDERS, HEMOLYTIC DISORDERS, AND OXIDATIVE STRESS-ASSOCIATED DISORDERS USING NRH, NARH AND REDUCED DERIVATIVES THEREOF MITOPOWER LLC (US) 2022-12-22 WO claimed
WO-2021098725-A1 SYNTHETIC METHOD FOR NMN DERIVATIVE AND MEDICAL APPLICATIONS OF NMN AND ITS DERIVATIVE TSINGHUA UNIVERSITY (CN) 2021-05-27 WO claimed
CN-103889224-B ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE PTC医疗公司 2017-05-24 CN claimed
CN-102115469-A Preparation method for indoline-2-one derivative and application of same UNIV ZHEJIANG 2011-07-06 CN claimed
JP-5339263-A None JP disclosed
JP-56061354-A None JP disclosed
US-20250388541-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-12-25 US disclosed
US-20250388543-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-12-25 US disclosed
US-20250367229-A1 Treatment of Immune-Related Disorders, Kidney Disorders, Liver Disorders, Hemolytic Disorders, and Oxidative Stress-Associated Disorders Using NRH, NARH and Reduced Derivatives Thereof MITOPOWER LLC (US) 2025-12-04 US disclosed
US-4645766-A 1,2-dihydro-2-oxo-3-hydroxymethyl pyridines, compositions and use THE UPJOHN COMPANY (US) 1987-02-24 US disclosed
EP-0194750-A1 Dihydropyridine alkanol amines, process for their preparation and pharmaceutical compositions containing them IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1986-09-17 EP disclosed
WO-1986004581-A1 DIHYDROPYRIDINE ALKANOLAMINES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1986-08-14 WO disclosed
US-4288440-A Pyridinones THE UPJOHN COMPANY (US) 1981-09-08 US disclosed
JP-S5661354-A NICOTINIC ACID DERIVATIVE MITSUBISHI CHEM IND LTD 1981-05-26 JP disclosed